Serveur d'exploration sur SGML

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Intrinsic Activity at the Molecular Level: E. J. Ariëns' Concept Visualized

Identifieur interne : 000311 ( France/Analysis ); précédent : 000310; suivant : 000312

Intrinsic Activity at the Molecular Level: E. J. Ariëns' Concept Visualized

Auteurs : Donald J. Abraham [États-Unis] ; Jean Kister [France] ; Gajanan S. Joshi [États-Unis] ; Michael C. Marden [France] ; Claude Poyart [France]

Source :

RBID : ISTEX:BE75F07EC89BE529F815FEC5EAE90EE30A452A78

English descriptors

Abstract

Abstract: The concept of using affinity and intrinsic activity to analyze drug interactions with receptors has had a long history in pharmacological studies. In the simplest case, the biological response will be proportional to the amount of drug bound, i.e. its affinity. However, the biological response is also mediated by the ability of a drug when bound to exert its maximum effectiveness. This effectiveness is termed the intrinsic activity. Physicochemical processes have been thought to be at the basis of intrinsic activity. Detailed oxygen and solution binding experiments combined with X-ray crystallographic studies on allosteric effectors to hemoglobin demonstrate that these potential drug agents bind at the same site in hemoglobin with similar binding constants yet shift the allosteric equilibrium and the oxygen affinity of the T-structure by different degrees. Therefore some of the effectors with similar binding affinities for the same site exhibit varying degrees of affectiveness, i.e. they possess different intrinsic activities. The intrinsic activity of the effector is defined as the ratio of the oxygen affinity constant to the T-state with drug/oxygen affinity constant to the T-state without drug (KT+drug)/(KT control). The source of the intrinsic activity appears to be the ability of the effectors to interact with key residues such as Lys99α at the binding site. These results suggest a general molecular mechanism for allosteric effector modulation of hemoglobin function that might be of use in other allosteric enzyme systems.

Url:
DOI: 10.1006/jmbi.1995.0265


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:BE75F07EC89BE529F815FEC5EAE90EE30A452A78

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Intrinsic Activity at the Molecular Level: E. J. Ariëns' Concept Visualized</title>
<author>
<name sortKey="Abraham, Donald J" sort="Abraham, Donald J" uniqKey="Abraham D" first="Donald J." last="Abraham">Donald J. Abraham</name>
</author>
<author>
<name sortKey="Kister, Jean" sort="Kister, Jean" uniqKey="Kister J" first="Jean" last="Kister">Jean Kister</name>
</author>
<author>
<name sortKey="Joshi, Gajanan S" sort="Joshi, Gajanan S" uniqKey="Joshi G" first="Gajanan S." last="Joshi">Gajanan S. Joshi</name>
</author>
<author>
<name sortKey="Marden, Michael C" sort="Marden, Michael C" uniqKey="Marden M" first="Michael C." last="Marden">Michael C. Marden</name>
</author>
<author>
<name sortKey="Poyart, Claude" sort="Poyart, Claude" uniqKey="Poyart C" first="Claude" last="Poyart">Claude Poyart</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BE75F07EC89BE529F815FEC5EAE90EE30A452A78</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1006/jmbi.1995.0265</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-RHR45HF1-5/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003112</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003112</idno>
<idno type="wicri:Area/Istex/Curation">002642</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A96</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002A96</idno>
<idno type="wicri:doubleKey">0022-2836:1995:Abraham D:intrinsic:activity:at</idno>
<idno type="wicri:Area/Main/Merge">003143</idno>
<idno type="wicri:Area/Main/Curation">002F73</idno>
<idno type="wicri:Area/Main/Exploration">002F73</idno>
<idno type="wicri:Area/France/Extraction">000311</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Intrinsic Activity at the Molecular Level: E. J. Ariëns' Concept Visualized</title>
<author>
<name sortKey="Abraham, Donald J" sort="Abraham, Donald J" uniqKey="Abraham D" first="Donald J." last="Abraham">Donald J. Abraham</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298</wicri:regionArea>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kister, Jean" sort="Kister, Jean" uniqKey="Kister J" first="Jean" last="Kister">Jean Kister</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U299, Hôspital de Bicêtre 94275 Le Kremlin, Bicêtre</wicri:regionArea>
<wicri:noRegion>Bicêtre</wicri:noRegion>
<wicri:noRegion>Bicêtre</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Joshi, Gajanan S" sort="Joshi, Gajanan S" uniqKey="Joshi G" first="Gajanan S." last="Joshi">Gajanan S. Joshi</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298</wicri:regionArea>
<placeName>
<region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Marden, Michael C" sort="Marden, Michael C" uniqKey="Marden M" first="Michael C." last="Marden">Michael C. Marden</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U299, Hôspital de Bicêtre 94275 Le Kremlin, Bicêtre</wicri:regionArea>
<wicri:noRegion>Bicêtre</wicri:noRegion>
<wicri:noRegion>Bicêtre</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Poyart, Claude" sort="Poyart, Claude" uniqKey="Poyart C" first="Claude" last="Poyart">Claude Poyart</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U299, Hôspital de Bicêtre 94275 Le Kremlin, Bicêtre</wicri:regionArea>
<wicri:noRegion>Bicêtre</wicri:noRegion>
<wicri:noRegion>Bicêtre</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Molecular Biology</title>
<title level="j" type="abbrev">YJMBI</title>
<idno type="ISSN">0022-2836</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">248</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="845">845</biblScope>
<biblScope unit="page" to="855">855</biblScope>
</imprint>
<idno type="ISSN">0022-2836</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-2836</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>allostery</term>
<term>effectors</term>
<term>hemoglobin</term>
<term>oxygen affinity</term>
<term>red cell</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Abraham</term>
<term>Academic press</term>
<term>Allosteric</term>
<term>Allosteric contribution</term>
<term>Allosteric effector</term>
<term>Allosteric effectors</term>
<term>Allosteric equilibrium</term>
<term>Allosteric model</term>
<term>Allosteric parameters</term>
<term>Allosteric transition</term>
<term>Allsoteric effectors</term>
<term>Amide</term>
<term>Amide bond</term>
<term>Amide oxygen atom</term>
<term>Ariens</term>
<term>Aromatic rings</term>
<term>Association binding</term>
<term>Binding site</term>
<term>Binding sites</term>
<term>Biol</term>
<term>Biological response</term>
<term>Central chain</term>
<term>Chem</term>
<term>Control cells</term>
<term>Different complexes</term>
<term>Different degrees</term>
<term>Diffraction study</term>
<term>Effector</term>
<term>Effector activity</term>
<term>Experimental results</term>
<term>Groupd series</term>
<term>Hemoglobin</term>
<term>Hemoglobin function</term>
<term>Hill plot</term>
<term>Human hemoglobin</term>
<term>Hydrophobic interactions</term>
<term>Inositol hexaphosphate</term>
<term>Intrinsic</term>
<term>Intrinsic activity</term>
<term>Intrinsic activity factor</term>
<term>Intrinsic oxygen</term>
<term>Kaff</term>
<term>Kaff values</term>
<term>Kellogg</term>
<term>Kister</term>
<term>Lalezari</term>
<term>Ligand program</term>
<term>Long history</term>
<term>Maximum contraction</term>
<term>Mmhg</term>
<term>Molecular level</term>
<term>Molecular level table</term>
<term>Natl acad</term>
<term>Oxygen binding</term>
<term>Oxygen binding curve</term>
<term>Oxygen binding studies</term>
<term>Oxygen dissociation curves</term>
<term>Oxygen equilibrium curve</term>
<term>Oxygen saturation</term>
<term>Partial pressure</term>
<term>Perutz</term>
<term>Pharmacological studies</term>
<term>Phosphate buffer</term>
<term>Potential antisickling agents</term>
<term>Poyart</term>
<term>Randad</term>
<term>Receptor</term>
<term>Receptor system</term>
<term>Same site</term>
<term>Scatchard plots</term>
<term>Similar association constants</term>
<term>Similar binding</term>
<term>Similar binding constants</term>
<term>Simplest case</term>
<term>Small effect</term>
<term>Sodium dithionite</term>
<term>Solution binding studies</term>
<term>Standard curves</term>
<term>Standard error</term>
<term>Subunit</term>
<term>Tetramera kaffb</term>
<term>Universite paris</term>
<term>Virginia commonwealth university</term>
<term>Weaker effectors</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The concept of using affinity and intrinsic activity to analyze drug interactions with receptors has had a long history in pharmacological studies. In the simplest case, the biological response will be proportional to the amount of drug bound, i.e. its affinity. However, the biological response is also mediated by the ability of a drug when bound to exert its maximum effectiveness. This effectiveness is termed the intrinsic activity. Physicochemical processes have been thought to be at the basis of intrinsic activity. Detailed oxygen and solution binding experiments combined with X-ray crystallographic studies on allosteric effectors to hemoglobin demonstrate that these potential drug agents bind at the same site in hemoglobin with similar binding constants yet shift the allosteric equilibrium and the oxygen affinity of the T-structure by different degrees. Therefore some of the effectors with similar binding affinities for the same site exhibit varying degrees of affectiveness, i.e. they possess different intrinsic activities. The intrinsic activity of the effector is defined as the ratio of the oxygen affinity constant to the T-state with drug/oxygen affinity constant to the T-state without drug (KT+drug)/(KT control). The source of the intrinsic activity appears to be the ability of the effectors to interact with key residues such as Lys99α at the binding site. These results suggest a general molecular mechanism for allosteric effector modulation of hemoglobin function that might be of use in other allosteric enzyme systems.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Virginie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Virginie">
<name sortKey="Abraham, Donald J" sort="Abraham, Donald J" uniqKey="Abraham D" first="Donald J." last="Abraham">Donald J. Abraham</name>
</region>
<name sortKey="Joshi, Gajanan S" sort="Joshi, Gajanan S" uniqKey="Joshi G" first="Gajanan S." last="Joshi">Gajanan S. Joshi</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Kister, Jean" sort="Kister, Jean" uniqKey="Kister J" first="Jean" last="Kister">Jean Kister</name>
</noRegion>
<name sortKey="Marden, Michael C" sort="Marden, Michael C" uniqKey="Marden M" first="Michael C." last="Marden">Michael C. Marden</name>
<name sortKey="Poyart, Claude" sort="Poyart, Claude" uniqKey="Poyart C" first="Claude" last="Poyart">Claude Poyart</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/SgmlV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000311 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000311 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Informatique
   |area=    SgmlV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:BE75F07EC89BE529F815FEC5EAE90EE30A452A78
   |texte=   Intrinsic Activity at the Molecular Level: E. J. Ariëns' Concept Visualized
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Jul 1 14:26:08 2019. Site generation: Wed Apr 28 21:40:44 2021